10 organisations and individuals were recognised for their significant contributions on 24 March, at the 5th BioPharma Industry Awards Gala Dinner, held in conjunction with the 8th BioPharma Asia Convention 2015. The award winners are as follows.
Best Contract Research Organisation — PRA Health Sciences
Best Contract Manufacturing Organisation — Kemwell BioPharma, India
Best Cold Chain Packaging Solutions Provider — ThermoSafe Brands
Best Life Sciences Logistics Solutions Provider — Marken
Process Manufacturing Category
Best Upstream Process Manufacturing Solution Provider — GE Healthcare
Best Downstream Process Manufacturing Solution Provider — Merck Millipore
Therapeutics Innovators Category
Most Innovative Biotech of the Year — Sentinext Therapeutics
Pharma of the Year — Novartis
Executive of the Year Category
Asian Male Executive of the Year — Anand Tharmaratnam, Senior Vice President, Head of Asia Markets, Quintiles East Asia, Singapore
Asian Woman Executive of the Year — Kiran Mazumdar Shaw, Managing Director & CEO, Biocon, India
All finalists had undergone a 2 stage stringent voting process within the Life Sciences Community across a 4 month window. The 10 award winners were spoken highly of from the hundreds of voters and it was comforting to know that each winner and finalist was spurred to do even better in the months ahead.
“The industry has indeed spoken and it is great to definitely have so much praise given to these people. We look forward to even more contributions from the award winners and from the rest of the industry,” said Kenneth Lai, Project Manager, BioPharma Asia Convention 2015. “With Asia’s advancements in the biopharmaceutical space, it is ever more important now that these leaders and the rest of the industry to quickly step up and leverage on all the opportunities so as to stay competitive in this industry.”
The BioPharma Asia Convention 2015 closed this year’s proceedings and saw more than 1,200+ attendees. Asia’s most important biopharmceutical industry gathering saw more 100+ conversations on how to best navigate Asia’s future in the biopharmaceutical sector and hosted more than 110 thoughts leaders and key decision makers joining us as speakers of the industry.